Clinical Challenges and Images in Gastroenterology : (Record no. 16007)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 11289nam a22004933i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC6036813 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240724114117.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2018 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781910079041 |
| Qualifying information | (electronic bk.) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC6036813 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL6036813 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1124301814 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC801 |
| Item number | .N4 2018 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.330754 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ng, Siew C. |
| 245 10 - TITLE STATEMENT | |
| Title | Clinical Challenges and Images in Gastroenterology : |
| Remainder of title | A Diagnostic Guide. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Shrewsbury : |
| Name of producer, publisher, distributor, manufacturer | TFM Publishing Limited, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2018. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2018. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (346 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Clinical Challenges & -- Images in GASTROENTEROLOGY: A Diagnostic Guide -- Title Page -- Copyright -- Contents -- Preface -- Abbreviations -- Acknowledgements -- Dedication -- Case 1 -- History -- What is your differential diagnosis? -- Physical examination -- Does this narrow your differential diagnosis? -- Investigations -- What other blood tests would you order? -- What do these laboratory data suggest? -- What imaging test would you order? -- Please describe what you see -- How would you proceed? -- What is your differential diagnosis for necrotising lymphadenitis? -- Infection -- Autoimmune -- Malignancy -- What is the diagnosis, and how would you proceed? -- Clinical pearls -- Impress your attending -- What virus is implicated as a possible cause for NK/T-cell lymphoma? -- What is the prevalence of extranodal NK/T-cell lymphomas in East Asia? -- What is the prognosis of non-nasal NK/T-cell lymphoma? -- What do you know about the SMILE regimen? -- References -- Case 2 -- History -- Physical examination -- Investigations -- What is your differential diagnosis? -- What other blood tests would you order? -- What do these laboratory data suggest? -- What other tests would you order? -- What imaging test would you order? -- Please describe what you see -- What is your diagnosis, and how would you proceed? -- What would you do next? -- Please describe what you see -- What is your differential diagnosis? -- How would you manage this patient? -- Clinical pearls -- Impress your attending -- How common is tuberculosis of the intestinal tract? -- What are the risk factors for tuberculosis of the intestinal tract? -- What is the presentation of intestinal tuberculosis? -- What is the duration of anti-tuberculosis treatment if the gut is affected? -- Do you know of any new drugs for the treatment of tuberculosis? -- References -- Case 3 -- History. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | What is your differential diagnosis? -- Physical examination -- Does this narrow your differential diagnosis? What diagnosis does the physical examination suggest? -- Investigations -- What other blood tests would you order? -- What do these laboratory data suggest? -- How would you proceed? -- Please describe what you see -- What imaging test would you order? -- Please describe what you see -- What is the diagnosis, and how would you proceed? -- What is the next step? -- Clinical pearls -- Impress your attending -- What is the definition of a granuloma? -- How would you distinguish between Crohn's disease and ITB (Table 3.1)? -- References -- Case 4 -- History -- Physical examination -- Investigations -- What is your differential diagnosis? -- What other tests would you order? -- How would you assess the severity of the flare? -- How would you manage his flare? -- How would you proceed? -- What is the first-line management? -- What other medical rescue therapies are available for a steroid-refractory ulcerative colitis flare? -- How would you proceed? -- Please describe what you see -- Clinical pearls -- Impress your attending -- What precautions are necessary to prevent the spread of the Clostridium difficile infection? -- References -- Case 5 -- History -- Physical examination -- Investigations -- What are the possible causes of his fever given his history of Crohn's? -- What further investigations would you perform? -- Please describe what you see -- Later on, the ZN stain shows acid-fast bacilli. How would this affect your management? -- Clinical pearls -- Impress your attending -- How would you screen for TB? -- What are the possible causes of a false-negative Mantoux test? -- What can cause a false-positive Mantoux test result? -- What is the performance of interferon-. release assays in the diagnosis of latent TB (Table 5.1)?. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | What would be your approach if the patient has latent tuberculosis? -- What are the potential side effects from the therapy? -- References -- Case 6 -- History -- Physical examination -- What is your differential diagnosis? -- What blood test(s) would you order? -- What further investigations would you order? -- Please describe what you see -- Does this narrow your differential diagnosis? -- In colonoscopy, what are the features suggestive of Behçet's disease? -- On histological examination, what is the important feature that differentiates Crohn's from Behçet's disease? -- What is a pathergy test and how would you perform it? -- What other skin manifestations may be seen in Behçet's disease? -- What are the diagnostic criteria for Behçet's disease? -- What are the treatment options for Behçet's disease? -- Clinical pearls -- Impress your attending -- How frequent are GI symptoms in patients with Behçet's disease? -- References -- Case 7 -- History -- Physical examination -- Please describe what you see -- Investigations -- What are the potential causes for the skin lesions? -- How would you manage this patient? -- What further investigations would you request? -- Please describe what you see -- Clinical pearls -- Impress your attending -- What is pancreatic panniculitis? -- Which pancreatic malignancy is most strongly associated with the development of pancreatic panniculitis? -- What is Schmid's triad? -- References -- Case 8 -- History -- Physical examination -- Please describe what you see -- Investigations -- What is your differential diagnosis? -- What would you do next? -- Please describe what you see -- What is the most compatible diagnosis? -- Clinical pearls -- Impress your attending -- What are the systemic diseases associated with pyoderma gangrenosum? -- How would you manage this patient?. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | What other extra-intestinal manifestations (EIM) of inflammatory bowel disease do you know of? -- References -- Case 9 -- History -- Physical examination -- Investigations -- What is your differential diagnosis? -- What further investigations would you arrange? -- Please describe what you see -- Does this narrow your differential diagnosis? -- How would you treat this patient? -- Please describe what you see -- What is the final diagnosis? -- Clinical pearls -- Impress your attending -- What organ systems can be affected by IgG4-related disease (Table 9.1)? -- What is the treatment for IgG4-related disease? -- Do you know of any new biomarkers under investigation for the use in IgG4-related disease? -- References -- Case 10 -- History -- Physical examination -- Investigations -- Please describe what you see -- What is the likely diagnosis? -- How would you manage this patient? -- Clinical pearls -- Impress your attending -- What C. difficile toxins do you know of? -- What is the incidence of Clostridium difficile-associated disease? -- What are the risk factors for CDAD? -- How would you distinguish between non-severe and severe (fulminant) CDAD (Table 10.1)? -- How would you manage patients with CDAD (Figures 10.2 and 10.3)? -- Is there any evidence supporting the use of faecal microbiota transplantation (FMT) for recurrent CDAD? -- References -- Case 11 -- History -- Physical examination -- Investigations -- What is your differential diagnosis? -- What would you do next? -- Please describe what you see -- What is the working diagnosis? -- What would you do next? -- Clinical pearls -- Impress your attending -- What is the nature of the pain in this condition? -- What are the causes of haemosuccus pancreaticus? -- References -- Case 12 -- History -- Physical examination -- Investigations -- What is your working diagnosis? -- How would you proceed?. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Please describe what you see -- What would be the next step of management? -- What therapy was given to this patient? -- Clinical pearls -- Impress your attending -- What are the risk factors for HCC? -- What tests are used as surveillance for HCC in at-risk populations? -- Do you know of any newer biomarkers? -- How is HCC staged? -- In patients with HCC and cirrhosis, which patients are generally deemed suitable for the consideration of liver transplantation? -- What chemotherapeutic agents are injected during a session of TACE? -- What is post-embolisation syndrome? -- References -- Case 13 -- History -- Physical examination -- Investigations -- What would you do next? -- Please describe what you see -- How would you treat this patient? -- Clinical pearls -- Impress your attending -- What are the limitations of CA 19-9? -- Do you know of any poor prognostic factors for pancreatic cancer? -- What is the prognosis of pancreatic adenocarcinoma? -- What would be the choice of chemotherapy after curative resection? -- References -- Case 14 -- History -- Physical examination -- Investigations -- How would you manage this lady? -- What is your differential diagnosis for the mass? -- What imaging test would you order next? -- Please describe what you see -- What further investigations would you request? -- Please describe what you see -- What is your diagnosis? -- What would be your next step? -- Clinical pearls -- Impress your attending -- What do you know about the genetics of neurofibromatosis Type 1? -- What are the gastrointestinal manifestations of neurofibromatosis Type 1? -- How would you treat GISTs? -- What are good prognostic factors for GIST recurrence after surgery? -- Is there a role for adjuvant imatinib? -- How would you decide the timing of resumption of anticoagulation? -- References -- Case 15 -- History -- Physical examination. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Investigations. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | With a special focus on the interpretation of endoscopic and radiological images, this book provides a pragmatic approach for medical students, residents, specialist trainees and specialists alike who have an interest in gastroenterology. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gastroenterology. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chan, Heyson Ch. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lui, Rashid Ns. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Ng, Siew C. |
| Title | Clinical Challenges and Images in Gastroenterology |
| Place, publisher, and date of publication | Shrewsbury : TFM Publishing Limited,c2018 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=6036813">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=6036813</a> |
| Public note | Click to View |
No items available.